BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 549786)

  • 1. [Hypoxic pulmonary vasoconstriction and angiotensin II blockade in calves (author's transl)].
    Mattioli L; Zakheim RM; Toyama M; Park MK; Molteni A; Vaseenon T; Nicolosi GL; Zanuttini D
    G Ital Cardiol; 1979; 9(12):1382-5. PubMed ID: 549786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of saralasin acetate, a competitive inhibitor of angiotensin II, to diminish alveolar hypoxic vasoconstriction in the dog.
    Hales CA; Rouse ET; Kazemi H
    Cardiovasc Res; 1977 Nov; 11(6):541-6. PubMed ID: 603879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor blockade and effects on pulmonary hemodynamics and hypoxic pulmonary vasoconstriction in humans.
    Kiely DG; Cargill RI; Lipworth BJ
    Chest; 1996 Sep; 110(3):698-703. PubMed ID: 8797414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II prevents hypoxic pulmonary hypertension and vascular changes in rat.
    Rabinovitch M; Mullen M; Rosenberg HC; Maruyama K; O'Brodovich H; Olley PM
    Am J Physiol; 1988 Mar; 254(3 Pt 2):H500-8. PubMed ID: 3348429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs.
    McMurtry IF; Davidson AB; Reeves JT; Grover RF
    Circ Res; 1976 Feb; 38(2):99-104. PubMed ID: 1245025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1979 George Simon Memorial Fellowsip Award. A radiologic and physiologic investigation into hypoxic pulmonary vasoconstriction in the dog.
    Allison DJ; Stanbrook HS
    Invest Radiol; 1980; 15(3):178-90. PubMed ID: 7399842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulating effects of angiotensin I, angiotensin II and des-Asp1-angiotensin II on steroid production in vitro and its inhibition by Sar1-Ala8-angiotensin II.
    Hepp R; Grillet C; Peytremann A; Vallotton MB
    Prog Biochem Pharmacol; 1976; 12():41-8. PubMed ID: 1019169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic hypoxia on angiotensin-induced pulmonary vasoconstriction and converting enzyme activity in the rat.
    Caldwell RW; Blatteis CM
    Proc Soc Exp Biol Med; 1983 Mar; 172(3):346-50. PubMed ID: 6302709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II and [Sar1, Ile5, Ala8]angiotensin II effect on contractile activity and prostaglandin production of in vitro pregnant rat uteri.
    Dubin NH; Ghodgaonkar RB
    Endocrinology; 1980 Dec; 107(6):1855-60. PubMed ID: 7428693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin is not required for hypoxic constriction in salt solution-perfused rat lungs.
    McMurtry IF
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Feb; 56(2):375-80. PubMed ID: 6561197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a histaminergic mechanism on the effects of angiotensin II in the rabbit aorta and rat lung.
    Zengil H
    Arch Int Pharmacodyn Ther; 1981 Jul; 252(1):67-71. PubMed ID: 7305553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A carboxy-terminus truncated analogue of angiotensin II, [Sar1]angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists.
    Bovy PR; Trapani AJ; McMahon EG; Palomo M
    J Med Chem; 1989 Mar; 32(3):520-2. PubMed ID: 2918497
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of angiotensin on hypoxic pulmonary vasoconstriction in isolated dog lung.
    Alexander JM; Nyby MD; Jasberg KA
    J Appl Physiol; 1976 Jul; 41(1):84-8. PubMed ID: 972137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
    Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will chronic intracerebroventricular saralasin infusion produce selective blockade of brain angiotensin II receptors in the rat?
    Bruner CA; Weaver JM; Fink GD
    J Pharmacol Exp Ther; 1983 Jul; 226(1):13-8. PubMed ID: 6306220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytochrome P-450 in alveolar hypoxic pulmonary vasoconstriction in dogs.
    Miller MA; Hales CA
    J Clin Invest; 1979 Aug; 64(2):666-73. PubMed ID: 457876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of the humoral and arterial pressure responses to Sar1-Ala8-, Sar1-Ile8 and Sar1-Thr8-angiotensin II in the trained unanaesthetized dog.
    Bravo EL; Khosla MC; Bumpus FM
    Prog Biochem Pharmacol; 1976; 12():33-40. PubMed ID: 1019168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal vascular responses to infusions of 1-sarcosine-8-alanine-angiotensin II (saralasin) in man and dog [proceedings].
    Lewis PS; Wilcox CS
    J Physiol; 1978 Jul; 280():42P-43P. PubMed ID: 690897
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine and saralasin antagonism of renal vasoconstriction and oliguria caused by amphotericin B in dogs.
    Reiner NE; Thompson WL
    J Infect Dis; 1979 Oct; 140(4):564-75. PubMed ID: 512416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.